Perspective review highlights class effects and dosing optimization in tegoprazan–amoxicillin dual therapy, suggesting refined surveillance strategies against antibiotic resistance.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ye et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: